Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 公共衛生學院
  3. 流行病學與預防醫學研究所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/28124
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor陳秀熙
dc.contributor.authorWei-Hsu Koen
dc.contributor.author柯威旭zh_TW
dc.date.accessioned2021-06-13T00:01:21Z-
dc.date.available2012-08-08
dc.date.copyright2007-08-08
dc.date.issued2007
dc.date.submitted2007-07-30
dc.identifier.citationAdami et al. (1991) Cancer risk in patients with diabetes mellitus. Cancer Causes Control 1991;2:307-14.
Adami et al. (1996) Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 1996;88:1472-7.
Bahrami. (2006) Causal models in primary open angle glaucoma. Ophthalmic Epidemiol 2006;13:291-8.
Beasley et al. (1981) Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 1981;2:1129-33.
Bokhout et al. (2000) A 'sufficient cause' model for dental caries. J Epidemiol Biostat 2000;5:203-8.
Braga et al. (1997) Attributable risks for hepatocellular carcinoma in northern Italy. Eur J Cancer 1997;33:629-34.
Bruzzi et al. (1985) Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol 1985;122:904-14.
Chang et al. (1997) Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997;336:1855-9.
Chen (1990) Hepatitis B virus infection, its sequelae, and prevention in Taiwan. In: Okuda K, Ishak KG, eds. Neoplasms of the liver. Tokyo:Springer-Verlag, 1987. 71-80
Chen et al. (1990) Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis 1990;162:817-22.
Chen et al. (2007) Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J Formos Med Assoc 2007;106:148-55.
Chou et al. (2001) Epidemiology of type 2 diabetes in Taiwan. Diabetes Res Clin Pract 2001;54 Suppl 1:S29-35.
Chuang et al. (1992) The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case-control study. Cancer 1992;69:2052-4.
Coughlin et al. (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 2004;159:1160-7.
Davila et al. (2005) Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 2005;54:533-9.
Dupont. (1988) Power calculations for matched case-control studies. Biometrics 1988;44:1157-1168.
El-Serag et al. (2006) The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 2006;4:369-80.
El-Serag et al. (2001) The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans. Am J Gastroenterol 2001;96:2462-7.
El-Serag et al. (2004) Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004;126:460-8.
Ferlay et al. (2001) GLOBOCAN 2000: Cancer incidence, mortality and prevalence worldwide, Version 1.0. Lyon: IARC PRESS.
Fleiss. (1981) Statistical Methods for Rates and Proportions. 2nd Ed. New York: John Wiley & Sons, 1981
Fukuda et al. (1993) A hospital-based case-control study on hepatocellular carcinoma in Fukuoka and Saga Prefectures, northern Kyushu, Japan. Jpn J Cancer Res 1993;84:708-14.
Greenland and Brumback. (2002) An overview of relations among causal modelling methods. Int J Epidemiol 2002;31:1030-7.
Hadziyannis et al. (1995) A case-control study of hepatitis B and C virus infections in the etiology of hepatocellular carcinoma. Int J Cancer 1995;60:627-31.
Harrison. (2006) Liver disease in patients with diabetes mellitus. J Clin Gastroenterol 2006;40:68-76.
Hassan et al. (2002) Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002;36:1206-13.
Hoffmann et al. (2006) Estimating the proportion of disease due to classes of sufficient causes. Am J Epidemiol 2006;163:76-83.
Hosmer and Lemeshow. (1992) Confidence interval estimation of interaction. Epidemiology 1992;3:452-6.
Huang et al. (2007) Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implication. Am J Gastroenterol 2007;102:1237-43.
Huo et al. (2003a) Diabetes mellitus is a recurrence-independent risk factor in patients with hepatitis B virus-related hepatocellular carcinoma undergoing resection. Eur J Gastroenterol Hepatol 2003;15:1203-8.
Huo et al. (2003b) Diabetes mellitus is a risk factor for hepatic decompensation in patients with hepatocellular carcinoma undergoing resection: a longitudinal study. Am J Gastroenterol 2003;98:2293-8.
IARC(International Agency for Research on Cancer) (1994) Hepatitis Viruses IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 59. IARC: Lyon, France. 1994.
Jee et al. (2005) Fasting serum glucose level and cancer risk in Korean men and women. Jama 2005;293:194-202.
La Vecchia et al. (1997) Diabetes mellitus and the risk of primary liver cancer. Int J Cancer 1997;73:204-7.
Lagiou et al. (2000) Role of diabetes mellitus in the etiology of hepatocellular carcinoma. J Natl Cancer Inst 2000;92:1096-9.
Lai et al. (2006) Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection. Hepatology 2006;43:1295-302.
Lawson et al. (1986) Diabetes mellitus and primary hepatocellular carcinoma. Q J Med 1986;61:945-55.
Lee et al. (1992) The prevalence of anti-hepatitis C virus among Chinese patients with hepatocellular carcinoma. Cancer 1992;69:342-5.
Lee et al. (1999) Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection. Cancer 1999;86:1143-50.
Levin (1953) The occurrence of lung cancer in man. Acta Union International Contra Cancrum. 1953;9:531-41.
Lu et al. (1988) A case-control study of primary hepatocellular carcinoma in Taiwan. Cancer 1988;62:2051-5.
Lu et al. (2006) Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan. Int J Cancer 2006;119:1946-52.
Mangia et al. (1998) HCV and diabetes mellitus: evidence for a negative association. Am J Gastroenterol 1998;93:2363-7.
Mangia et al. (1998) HCV and diabetes mellitus: evidence for a negative association. Am J Gastroenterol 1998;93:2363-7.
Mezzetti et al. (1996) Software for attributable risk and confidence interval estimation in case-control studies. Comput Biomed Res 1996;29:63-75.
Ni et al. (2007) Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies. Gastroenterology 2007;132:1287-93.
Ohata et al. (2003) Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer 2003;97:3036-43.
Pan et al. (2003) Prevalence and awareness of diabetes and mean fasting glucose by age, sex, and region: results from the Nutrition and Health Survey in Taiwan, 1993-1996. Diabet Med 2003;20:182-5.
Parkin et al. (1999) Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827-41.
Parkin et al. (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-6.
Perz et al. (2006) The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006;45:529-38.
Sasaki et al. (1996) A 15 year follow-up study of patients with non-insulin dependent diabetes mellitus (NIDDM) in Osaka, Japan. Long-term prognosis and causes of death. Diabetes Res Clin Pract 1996;34:47-55.
Rothman and Greenland. (1998) Modern Epidemiology. Philadelphia, Pa: Lippincott; 1998
Shibata et al. (1998) A case-control study on male hepatocellular carcinoma based on hospital and community controls. J Epidemiol 1998;8:1-5.
Sun et al. (2003) Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan. Am J Epidemiol 2003;157:674-82.
Sung et al. (1972) Hepatitis-associated antigen in hepatocellular carcinoma in Taiwan. Taiwan Yi Xue Hui Za Zhi 1972;71:505-8.
Taiwan Cancer Registration System. (2002) Available at http://crs.cph.ntu.edu.tw/
Tazawa et al. (2002) Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C. Dig Dis Sci 2002;47:710-5.
Toyoda et al. (2001) Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma. Cancer 2001;91:957-63.
Tseng et al. (2006) Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort. Diabetologia 2006;49:1755-60.
Uetake et al. (2003) Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection. Alcohol Clin Exp Res 2003;27:47S-51S.
Wang et al. (2003) Community-based study of hepatitis C virus infection and type 2 diabetes: an association affected by age and hepatitis severity status. Am J Epidemiol 2003;158:1154-60.
Wang et al. (2007) Hepatitis C Virus Infection and the Development of Type 2 Diabetes in a Community-based Longitudinal Study. Am J Epidemiol 2007.
Wideroff et al. (1997) Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 1997;89:1360-5.
WHO. (2003) The world health report 2003 - shaping the future. Available at http://www.who.int/whr/2003/en/
Whittemore. (1983) Estimating attributable risk from case-control studies. Am J Epidemiol 1983;117:76-85.
Yu et al. (1991a) Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res 1991;51:5621-5.
Yu et al. (1991b) Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst 1991;83:1820-6.
Yuan et al. (2004) Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S. Cancer 2004;101:1009-17.
Zendehdel et al. (2003) Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J Natl Cancer Inst 2003;95:1797-800.
行政院衞生署. (2007) http://www.doh.gov.tw/statistic/index.htm
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/28124-
dc.description.abstract充分原因模式(sufficient cause model)為流行病學家Rothman 於1976 年所提出。該模式的優點在於能藉此瞭解在引發疾病的多重致病因子間的交互作用。然而在過去的文獻中,該模式在實際臨床疾病的應用並不常見。在本論文中,我們利用肝細胞癌為例,在台灣此一慢性B 型肝炎及慢性C型肝炎盛行地區中,一項以醫院為基礎的病例對照研究,利用B 型肝炎、C 型肝炎及第二型糖尿病做為肝細胞癌致病因子,探討糖尿病與肝細胞癌發生之間的相關性。由上述研究,得知糖尿病與肝細胞癌的確有相關性,特別是在此一病毒型肝炎盛行的地區,對於無C 型肝炎者,具有2.62 倍的相關性;對於B 型肝炎帶原者,或無B 型肝炎者,糖尿病與肝細胞癌間約有2 到4 倍的相關性;且糖尿病與C 型肝炎之間,對於肝細胞癌的發生,並無協同交互作用。另外,對於無B型肝炎及C 型肝炎者,糖尿病與肝細胞癌2.15 倍相關性。在經過以數量方法建構肝細胞癌的充分原因模式,以探討致病因子間的交互作用、以辨明產生肝細胞癌的致病機轉之後,可將得到的危險比例進一步據以計算每一個充分原因模式之人口可歸因比例。在台灣此一糖尿病盛行率為7%之地區,糖尿病對於肝細胞癌之人口可歸因危險比例為18.7%。並進一步援引文獻中的調整方法,以及利用貝氏之圖形迴歸模式來計算當其它干擾因子存在時,經調整之後的糖尿病的人口可歸因危險比例能更真實反應出人口可歸因危險比例,來提供制訂公共衛生政策的參考。zh_TW
dc.description.abstractAmong causal models, a sufficient cause-component model differs from the other models in that it provides more information on causal mechanisms and defines biologic effects of several risk factors, particularly including strengths of association and their joint interaction effects. The advantage of looking at sufficient causes for the disease of interest is to give a clue to the mechanism of disease in question. We conducted a hospital-based case-control study with the inclusion of DM as a risk factor to elucidate the causal relationship leading to HCC after controlling for other major risk factors of HCC. In this hospital-based case control study, we corroborated the association between DM and HCC in Taiwan, where viral hepatitis B and C are hyperendemic. The estimated population attributable proportion indicated that diabetes accounted for 18.7% of HCC cases given 7% prevalence of diabetes. The independent contribution to the development of HCC cases in the absence of HBV and HCV infection was around 7.5%. In addition, we applied the method from the literature to calculate the adjusted population attributable proportion. We also developed a Bayesian acyclic graphic model to calculate the adjusted PAF and 95% confidence intervals.en
dc.description.provenanceMade available in DSpace on 2021-06-13T00:01:21Z (GMT). No. of bitstreams: 1
ntu-96-P94846005-1.pdf: 1048383 bytes, checksum: 392ae6e5420588018f415a47a12a8d5b (MD5)
Previous issue date: 2007
en
dc.description.tableofcontents口試委員會審定書
志謝
中文摘要
英文摘要
第一章 前言 1
第二章 文獻回顧 2
第一節 因果關係模式 2
第二節 肝細胞癌之流行病學 5
第三節 糖尿病與肝細胞癌相關性-病例對照研究 12
第四節 糖尿病與肝細胞癌相關性-世代研究 20
第五節 糖尿病與肝細胞癌預後的相關性 24
第六節 糖尿病在台灣的流行病學 25
第七節 C 型肝炎與糖尿病的相關性 26
第三章 材料與方法 27
第一節 樣本數估計 27
第二節 肝細胞癌病例組 30
第三節 對照組 30
第四節 肝細胞癌致病因子的收集 31
第五節 統計方法 32
一、協同指數與其信賴區間之計算 32
二、人口可歸因危險比例之計算-病例對照研究 33
三、人口可歸因危險比例之計算-貝氏定理應用 34
四、調整後之歸因比例 35
五、Levin 理論應用於多階段模式 37
六、Markov property assumption 39
七、以貝氏圖形迴歸模式計算人口可歸因危險比例 40
第四章 結果 44
第一節 人口學特徵 44
第二節 致病因子與肝細胞癌相關性分析 46
第三節 糖尿病、B 型肝炎與C 型肝炎三致病因子間之交互作用 50
第四節 以B 及C 型肝炎帶原狀態做為分層依據之分析 51
第五節 糖尿病與B 型肝炎間、糖尿病與C 型肝炎間之協同交互作用 53
第六節 人口可歸因危險比例 54
一、人口可歸因危險比例之計算-病例對照研究 55
二、人口可歸因危險比例之計算-貝氏定理應用 61
三、經調整後的人口可歸因危險比例 71
四、Levin 理論應用於多階段模式以計算人口可歸因危險比例 72
五、利用貝氏圖形迴歸模式計算糖尿病對肝細胞癌發生之人口可歸因危險比例 73
第五章 討論 80
第六章 結論 83
參考文獻 84
附錄 兩篇擬投稿之論文稿 91
表目錄
表2-1. 台灣地區因B 型肝炎及C 型肝炎引起肝細胞癌的比例 7
表2-2. 病例對照研究文獻回顧 8
表2-3. 世代研究文獻回顧 16
表3-1、樣本數估計 28
表4‐1. 病例組與對照組人口學特徵之比較 44
表4-2. 病例組與對照組致病因子比例分布之比較 45
表4-3. 二致病因子交互作用項之檢定 47
表4-4. 三致病因子交互作用項之檢定 48
表4-5. 各種複羅吉斯迴歸方程式之適合度 49
表4-6. 以B、C 型肝炎帶原狀態及糖尿病有無做為分層依據之與相關性分析 50
表4-7. 依B 或C 型肝炎狀態為分層依據之交互作用項之檢定 51
表4-8. 以B 及C 型肝炎帶原狀態來做為分層依據之糖尿病與肝細胞癌相關性 52
表4-9. 糖尿病與B 型肝炎間、糖尿病與C 型肝炎間之協同交互作用 53
表4-10. 各種致病因子組合成充分原因後,以粗勝算比計算之人口可歸因危險比例60
表4-11. 各種致病因子組合成充分原因後,以RR 計算之人口可歸因危險比例 68
表4-12. 糖尿病對於肝細胞癌經調整後之人口可歸因危險比例 71
表4-13. 條件式獨立之可歸因危險比例 72
表4-14. 糖尿病對肝細胞癌發生之粗人口可歸因危險比例 73
表4-15. 調整年齡後之糖尿病對肝細胞癌發生之人口可歸因危險比例 74
表4-16. 調整性別後之糖尿病對肝細胞癌發生之人口可歸因危險比例 75
表4-17. 調整B 型肝炎後之糖尿病對肝細胞癌發生之人口可歸因危險比例 76
表4-18. 調整C 型肝炎後之糖尿病對肝細胞癌發生之人口可歸因危險比例 77
表4-19. 調整年齡及性別後之糖尿病對肝細胞癌發生之人口可歸因危險比例 78
表4-20. 調整年齡與B 型肝炎後之糖尿病對肝細胞癌發生之人口可歸因危險比例 79
圖目錄
圖2-1.三個致病因子B、C 及D 對於疾病A 的充分原因模式的示意圖 3
圖3-1. 病例組與對照組選取流程圖 29
圖4-1.充分模式與相對應複羅吉斯迴歸方程式 54
圖4-2. 以勝算比計算之每一個充分原因模式之人口可歸因危險比例 56
圖4-3. 以RR 計算之每一個充分原因模式之人口可歸因危險比例 61
圖4-4. 利用互補推算所得之人口危險可歸比例與實際計算之比較 70
dc.language.isozh-TW
dc.subject病毒型肝炎zh_TW
dc.subject糖尿病zh_TW
dc.subject肝細胞癌zh_TW
dc.subject人口可歸因危險比例zh_TW
dc.subject相關性zh_TW
dc.subjecthepatocellular carcinomaen
dc.subjectviral hepatitisen
dc.subjectassociationen
dc.subjectpopulation attributable proportionen
dc.subjectDiabetes mellitusen
dc.title第二型糖尿病與肝細胞癌之相關性及其人口可歸因危險比例-在病毒型肝炎高盛行地區之病例對照研究zh_TW
dc.titleA case-control study for estimating the population attributable proportion and association between type 2 diabetes mellitus and hepatocellular carcinoma at a viral hepatitis hyperendemic areaen
dc.typeThesis
dc.date.schoolyear95-2
dc.description.degree碩士
dc.contributor.oralexamcommittee戴政,張淑惠,楊國卿,黃國晉
dc.subject.keyword糖尿病,肝細胞癌,人口可歸因危險比例,相關性,病毒型肝炎,zh_TW
dc.subject.keywordDiabetes mellitus,hepatocellular carcinoma,population attributable proportion,association,viral hepatitis,en
dc.relation.page90
dc.rights.note有償授權
dc.date.accepted2007-07-31
dc.contributor.author-college公共衛生學院zh_TW
dc.contributor.author-dept預防醫學研究所zh_TW
顯示於系所單位:流行病學與預防醫學研究所

文件中的檔案:
檔案 大小格式 
ntu-96-1.pdf
  未授權公開取用
1.02 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved